Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from RBC Capital

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts

In the last three months, 19 analysts have published ratings on Vertex Pharmaceuticals (NASDAQ:VRTX), offering a diverse range of perspectives from bullish to bearish.

Benzinga

A Glimpse Into The Expert Outlook On Energy Transfer Through 4 Analysts

Energy Transfer (NYSE:ET) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

DocuSign Stock Jumps On Strong Q3, Analysts Await Proof Of Sustained Growth

DocuSign stock climbed on better-than-expected Q3 results and strong guidance for Q4 and fiscal 2025, leading to price target increases from analysts.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Cracking The Code: Understanding Analyst Reviews For Smartsheet

13 analysts have expressed a variety of opinions on Smartsheet (NYSE:SMAR) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Benzinga

The Analyst Verdict: VSE In The Eyes Of 7 Experts

Ratings for VSE (NASDAQ:VSEC) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Key Takeaways From IDEX Analyst Ratings

Throughout the last three months, 4 analysts have evaluated IDEX (NYSE:IEX), offering a diverse set of opinions from bullish to bearish.

Benzinga

Key Takeaways From WESCO Intl Analyst Ratings

8 analysts have shared their evaluations of WESCO Intl (NYSE:WCC) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Expert Outlook: Atkore Through The Eyes Of 6 Analysts

Atkore (NYSE:ATKR) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Decoding 6 Analyst Evaluations For Pacira BioSciences

Across the recent three months, 6 analysts have shared their insights on Pacira BioSciences (NASDAQ:PCRX), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

Unveiling 13 Analyst Insights On Clearwater Analytics Hldg

Across the recent three months, 13 analysts have shared their insights on Clearwater Analytics Hldg (NYSE:CWAN), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

Decoding 17 Analyst Evaluations For Honeywell Intl

Analysts' ratings for Honeywell Intl (NASDAQ:HON) over the last quarter vary from bullish to bearish, as provided by 17 analysts.

Benzinga

Decoding 16 Analyst Evaluations For Global Payments

Global Payments (NYSE:GPN) underwent analysis by 16 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

Evaluating Globus Medical: Insights From 11 Financial Analysts

Globus Medical (NYSE:GMED) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Analyst Ratings For PagerDuty

Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on PagerDuty (NYSE:PD) in the last three months.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts

Analysts' ratings for Edwards Lifesciences (NYSE:EW) over the last quarter vary from bullish to bearish, as provided by 17 analysts.

Benzinga

Unveiling 12 Analyst Insights On Charter Communications

Ratings for Charter Communications (NASDAQ:CHTR) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Exxon Mobil Unusual Options Activity For November 26

Deep-pocketed investors have adopted a bearish approach towards Exxon Mobil (NYSE:XOM), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in XOM usually suggests something big is…

Benzinga

Critical Insights From Kodiak Gas Services Analyst Ratings: What You Need To Know

9 analysts have expressed a variety of opinions on Kodiak Gas Services (NYSE:KGS) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Where Kinder Morgan Stands With Analysts

In the latest quarter, 13 analysts provided ratings for Kinder Morgan (NYSE:KMI), showcasing a mix of bullish and bearish perspectives.

Benzinga

Deep Dive Into Summit Materials Stock: Analyst Perspectives (11 Ratings)

Summit Materials (NYSE:SUM) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

The Latest Analyst Ratings For CubeSmart

In the latest quarter, 9 analysts provided ratings for CubeSmart (NYSE:CUBE), showcasing a mix of bullish and bearish perspectives.

The Guardian - UK

Remember the global financial crisis? Well, high-risk securities are back

The shadow banking sector is trying its hand at trading in debt-based products such as collateralised loan obligations

The Guardian - UK

Lloyds shareholders could take £1bn hit over car finance crisis

Analysts forecast bank will have to halve £2bn buyback plan, as ex-boss of City regulator blames watchdog for crisis

Barchart

Ecolab Stock: Is Wall Street Bullish or Bearish?

Ecolab has outshone the broader market over the past year, and analysts are reasonably bullish about its future prospects.

Barchart

Buy This Growth Stock to Bet on AI-Powered Search

Investors can consider this growth stock to capitalize on the booming AI-powered search market, backed by robust growth prospects and promising stock performance.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.